chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Oropharyngeal discomfort, Somnolence
Clinical narrative: the room is spinning; if I stand up, I feel like I'm going to faint/ dizzy; felt it in my throat/ taste it in my throat; diarrhea; slept all day; felt weak; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (felt it in my throat/ taste it in my throat), DIARRHOEA (diarrhea), SOMNOLENCE (slept all day), ASTHENIA (felt weak) and VERTIGO (the room is spinning) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Thyroid disorder and Prediabetes.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (felt it in my throat/ taste it in my throat), DIARRHOEA (diarrhea), SOMNOLENCE (slept all day) and ASTHENIA (felt weak). On 24-Mar-2021, the patient experienced VERTIGO (the room is spinning) and DIZZINESS (if I stand up, I feel like I'm going to faint/ dizzy). On 24-Mar-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, OROPHARYNGEAL DISCOMFORT (felt it in my throat/ taste it in my throat), SOMNOLENCE (slept all day), ASTHENIA (felt weak), VERTIGO (the room is spinning) and DIZZINESS (if I stand up, I feel like I'm going to faint/ dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant medications included, thyroid and hypertension medications were reported.   Treatment information was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: the room is spinning; if I stand up, I feel like I'm going to faint/ dizzy; felt it in my throat/ taste it in my throat; diarrhea; slept all day; felt weak; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (felt it in my throat/ taste it in my throat), DIARRHOEA (diarrhea), SOMNOLENCE (slept all day), ASTHENIA (felt weak) and VERTIGO (the room is spinning) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Thyroid disorder and Prediabetes.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (felt it in my throat/ taste it in my throat), DIARRHOEA (diarrhea), SOMNOLENCE (slept all day) and ASTHENIA (felt weak). On 24-Mar-2021, the patient experienced VERTIGO (the room is spinning) and DIZZINESS (if I stand up, I feel like I'm going to faint/ dizzy). On 24-Mar-2021, DIARRHOEA (diarrhea) had resolved. At the time of the report, OROPHARYNGEAL DISCOMFORT (felt it in my throat/ taste it in my throat), SOMNOLENCE (slept all day), ASTHENIA (felt weak), VERTIGO (the room is spinning) and DIZZINESS (if I stand up, I feel like I'm going to faint/ dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Relevant concomitant medications included, thyroid and hypertension medications were reported.   Treatment information was not provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: severe unrelenting diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe unrelenting diarrhea) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIARRHOEA (severe unrelenting diarrhea). At the time of the report, DIARRHOEA (severe unrelenting diarrhea) outcome was unknown.            After 2nd dose, she states that she didn't saw that on the side effects list and is wondering if this is a side effect of the vaccine and What can she take. First dose of the vaccine was received 28 days before 23/MAR/2021 and had no side effects.  No concomitant medication details were provided. No treatment medication details were provided.
Age: 57.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Abdominal discomfort, Arthralgia, Blood pressure measurement, Chills, Headache
Clinical narrative: Hot at injection site; Upset stomach; Cannot sleep well at night; Painful at injection site; Swollen at injection site; Fever that reached 101.8 F; Red at injection site; Pain in all his joints; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site) and INJECTION SITE SWELLING (Swollen at injection site) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 038172114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBUPROFEN for Fever and Pain.    The patient's past medical history included No adverse event. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient started IBUPROFEN (unknown route) at an unspecified dose. On 23-Mar-2021, the patient experienced INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site), INJECTION SITE SWELLING (Swollen at injection site), PYREXIA (Fever that reached 101.8 F), INJECTION SITE ERYTHEMA (Red at injection site), ARTHRALGIA (Pain in all his joints), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site), INJECTION SITE SWELLING (Swollen at injection site), PYREXIA (Fever that reached 101.8 F), INJECTION SITE ERYTHEMA (Red at injection site), ARTHRALGIA (Pain in all his joints), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high mmHg (High) over 110. On an unknown date, Heart rate: high heart beats per minute (High) 120.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include 5 pills for blood pressure, gaud medication, stomach pills   This case was linked to US-MODERNATX, INC.-MOD-2021-056388 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056388:Case for first dose
Age: 57.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Heart rate, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Hot at injection site; Upset stomach; Cannot sleep well at night; Painful at injection site; Swollen at injection site; Fever that reached 101.8 F; Red at injection site; Pain in all his joints; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site) and INJECTION SITE SWELLING (Swollen at injection site) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 038172114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBUPROFEN for Fever and Pain.    The patient's past medical history included No adverse event. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient started IBUPROFEN (unknown route) at an unspecified dose. On 23-Mar-2021, the patient experienced INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site), INJECTION SITE SWELLING (Swollen at injection site), PYREXIA (Fever that reached 101.8 F), INJECTION SITE ERYTHEMA (Red at injection site), ARTHRALGIA (Pain in all his joints), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site), INJECTION SITE SWELLING (Swollen at injection site), PYREXIA (Fever that reached 101.8 F), INJECTION SITE ERYTHEMA (Red at injection site), ARTHRALGIA (Pain in all his joints), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high mmHg (High) over 110. On an unknown date, Heart rate: high heart beats per minute (High) 120.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include 5 pills for blood pressure, gaud medication, stomach pills   This case was linked to US-MODERNATX, INC.-MOD-2021-056388 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056388:Case for first dose
Age: 57.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Insomnia, Pyrexia
Clinical narrative: Hot at injection site; Upset stomach; Cannot sleep well at night; Painful at injection site; Swollen at injection site; Fever that reached 101.8 F; Red at injection site; Pain in all his joints; Chills; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site) and INJECTION SITE SWELLING (Swollen at injection site) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 038172114) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product IBUPROFEN for Fever and Pain.    The patient's past medical history included No adverse event. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient started IBUPROFEN (unknown route) at an unspecified dose. On 23-Mar-2021, the patient experienced INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site), INJECTION SITE SWELLING (Swollen at injection site), PYREXIA (Fever that reached 101.8 F), INJECTION SITE ERYTHEMA (Red at injection site), ARTHRALGIA (Pain in all his joints), CHILLS (Chills) and HEADACHE (Headaches). At the time of the report, INJECTION SITE WARMTH (Hot at injection site), ABDOMINAL DISCOMFORT (Upset stomach), INSOMNIA (Cannot sleep well at night), INJECTION SITE PAIN (Painful at injection site), INJECTION SITE SWELLING (Swollen at injection site), PYREXIA (Fever that reached 101.8 F), INJECTION SITE ERYTHEMA (Red at injection site), ARTHRALGIA (Pain in all his joints), CHILLS (Chills) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high mmHg (High) over 110. On an unknown date, Heart rate: high heart beats per minute (High) 120.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication include 5 pills for blood pressure, gaud medication, stomach pills   This case was linked to US-MODERNATX, INC.-MOD-2021-056388 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056388:Case for first dose
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: it was a little itchy; rash on their left arm where they got the shot; it was pink; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (it was a little itchy), VACCINATION SITE RASH (rash on their left arm where they got the shot) and VACCINATION SITE ERYTHEMA (it was pink) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 immunisation.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 19-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (it was a little itchy), VACCINATION SITE RASH (rash on their left arm where they got the shot) and VACCINATION SITE ERYTHEMA (it was pink). On 22-Mar-2021, VACCINATION SITE PRURITUS (it was a little itchy), VACCINATION SITE RASH (rash on their left arm where they got the shot) and VACCINATION SITE ERYTHEMA (it was pink) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified medications for high blood pressure.  treatment medication included hydrocortisone cream for the itching and an ice pack.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Frustration tolerance decreased, Insomnia, Pain, Paraesthesia
Clinical narrative: can't work; hyperparesthesia; can't sleep; hasn't gotten any sleep for the last 2 nights; suffering; extremely frustrated; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (can't work), PARAESTHESIA (hyperparesthesia), INSOMNIA (can't sleep), SLEEP DEFICIT (hasn't gotten any sleep for the last 2 nights) and PAIN (suffering) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), HYDRALAZINE and LOSARTAN POTASSIUM (LOSARTIN) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (can't work), PARAESTHESIA (hyperparesthesia), INSOMNIA (can't sleep), SLEEP DEFICIT (hasn't gotten any sleep for the last 2 nights), PAIN (suffering) and FRUSTRATION TOLERANCE DECREASED (extremely frustrated). At the time of the report, FEELING ABNORMAL (can't work), INSOMNIA (can't sleep), SLEEP DEFICIT (hasn't gotten any sleep for the last 2 nights), PAIN (suffering) and FRUSTRATION TOLERANCE DECREASED (extremely frustrated) outcome was unknown and PARAESTHESIA (hyperparesthesia) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: No specific follow-up information recorded. On 13-May-2021: AE start date and outcome, medical records of the pt On 14-May-2021: Email contained response only. On 11-Jun-2021: Non Significant Follow up
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep deficit
Clinical narrative: can't work; hyperparesthesia; can't sleep; hasn't gotten any sleep for the last 2 nights; suffering; extremely frustrated; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (can't work), PARAESTHESIA (hyperparesthesia), INSOMNIA (can't sleep), SLEEP DEFICIT (hasn't gotten any sleep for the last 2 nights) and PAIN (suffering) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), HYDRALAZINE and LOSARTAN POTASSIUM (LOSARTIN) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (can't work), PARAESTHESIA (hyperparesthesia), INSOMNIA (can't sleep), SLEEP DEFICIT (hasn't gotten any sleep for the last 2 nights), PAIN (suffering) and FRUSTRATION TOLERANCE DECREASED (extremely frustrated). At the time of the report, FEELING ABNORMAL (can't work), INSOMNIA (can't sleep), SLEEP DEFICIT (hasn't gotten any sleep for the last 2 nights), PAIN (suffering) and FRUSTRATION TOLERANCE DECREASED (extremely frustrated) outcome was unknown and PARAESTHESIA (hyperparesthesia) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: No specific follow-up information recorded. On 13-May-2021: AE start date and outcome, medical records of the pt On 14-May-2021: Email contained response only. On 11-Jun-2021: Non Significant Follow up
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pruritus, Pyrexia, Rash, Vaccination site erythema
Clinical narrative: hot injection site; itchy rash on hands; Rash on her hands; Fever; chills; injection site swollen; Red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot injection site), PRURITUS (itchy rash on hands), RASH (Rash on her hands), PYREXIA (Fever) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot injection site), PRURITUS (itchy rash on hands), RASH (Rash on her hands), CHILLS (chills), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (Red at injection site). 23-Mar-2021, the patient experienced PYREXIA (Fever). At the time of the report, VACCINATION SITE WARMTH (hot injection site), PRURITUS (itchy rash on hands), RASH (Rash on her hands), PYREXIA (Fever), CHILLS (chills), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (Red at injection site) outcome was unknown.            No treatment was reported.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: hot injection site; itchy rash on hands; Rash on her hands; Fever; chills; injection site swollen; Red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot injection site), PRURITUS (itchy rash on hands), RASH (Rash on her hands), PYREXIA (Fever) and CHILLS (chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE WARMTH (hot injection site), PRURITUS (itchy rash on hands), RASH (Rash on her hands), CHILLS (chills), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (Red at injection site). 23-Mar-2021, the patient experienced PYREXIA (Fever). At the time of the report, VACCINATION SITE WARMTH (hot injection site), PRURITUS (itchy rash on hands), RASH (Rash on her hands), PYREXIA (Fever), CHILLS (chills), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (Red at injection site) outcome was unknown.            No treatment was reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Vaccination site bruising
Clinical narrative: Received a subcutaneous injection, instead of intramuscular; Badly bruised arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Badly bruised arm) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Received a subcutaneous injection, instead of intramuscular) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Pemphigoid (Mucous membrane pemphigoid) since June 2015, Atrial fibrillation since February 2015, COPD since December 2018, Adhesive tape allergy, Hypertension since 2019, High cholesterol since 2019, Gout since 2009, Thyroid disorder since 2017, Diabetes since 2007, Allergy to antibiotic (Levaquin), Drug allergy (Vasotec), Drug allergy (Calan SR), Drug allergy (Lipitor) and Allergy to antibiotic (Doxycycline). Concomitant products included APIXABAN (ELIQUIS) for Atrial fibrillation, INSULIN GLARGINE (LANTUS) for Diabetes, FEBUXOSTAT (ULORIC) for Gout, PRAVASTATIN for Hyperlipidemia, DILTIAZEM and FUROSEMIDE (LASIX [FUROSEMIDE]) for Hypertension, CARVEDILOL for Hypertension and COPD, MYCOPHENOLATE MOFETIL and DAPSONE for Pemphigoid, LEVOTHYROXINE SODIUM (LEVOXYL) for Thyroid disorder, ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN D3 for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. In February 2021, the patient experienced VACCINATION SITE BRUISING (Badly bruised arm). On 18-Feb-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Received a subcutaneous injection, instead of intramuscular). On 18-Feb-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Received a subcutaneous injection, instead of intramuscular) had resolved. At the time of the report, VACCINATION SITE BRUISING (Badly bruised arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Added medical history and concomitant medications. Updated lot number and event.; Reporter's Comments: This report refers to a case of incorrect route of product administration for mRNA-1273 (lot # 024M20A) with no associated AEs reported.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: hurting between shoulder and elbow; soreness in left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (hurting between shoulder and elbow) and PAIN IN EXTREMITY (soreness in left arm) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced PAIN (hurting between shoulder and elbow) and PAIN IN EXTREMITY (soreness in left arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (hurting between shoulder and elbow) and PAIN IN EXTREMITY (soreness in left arm) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR with update to events, dose 2
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Feeling abnormal, Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: She felt bad; Runny nose; Metal taste in her mouth; Both lips tingling; Numb mouth; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt bad), RHINORRHOEA (Runny nose), DYSGEUSIA (Metal taste in her mouth), PARAESTHESIA ORAL (Both lips tingling) and HYPOAESTHESIA ORAL (Numb mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Historical condition reported).   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced FEELING ABNORMAL (She felt bad), RHINORRHOEA (Runny nose), DYSGEUSIA (Metal taste in her mouth), PARAESTHESIA ORAL (Both lips tingling), HYPOAESTHESIA ORAL (Numb mouth), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, FEELING ABNORMAL (She felt bad), RHINORRHOEA (Runny nose), DYSGEUSIA (Metal taste in her mouth), PARAESTHESIA ORAL (Both lips tingling), HYPOAESTHESIA ORAL (Numb mouth), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: She felt bad; Runny nose; Metal taste in her mouth; Both lips tingling; Numb mouth; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (She felt bad), RHINORRHOEA (Runny nose), DYSGEUSIA (Metal taste in her mouth), PARAESTHESIA ORAL (Both lips tingling) and HYPOAESTHESIA ORAL (Numb mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No Historical condition reported).   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced FEELING ABNORMAL (She felt bad), RHINORRHOEA (Runny nose), DYSGEUSIA (Metal taste in her mouth), PARAESTHESIA ORAL (Both lips tingling), HYPOAESTHESIA ORAL (Numb mouth), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, FEELING ABNORMAL (She felt bad), RHINORRHOEA (Runny nose), DYSGEUSIA (Metal taste in her mouth), PARAESTHESIA ORAL (Both lips tingling), HYPOAESTHESIA ORAL (Numb mouth), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not applicable.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Vaccination site swelling
Clinical narrative: soreness at the shoulder; swollen injection site; sore shoulder muscle; swollen lymph nodes at the clavicle lateral to the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes at the clavicle lateral to the injection site), ARTHRALGIA (soreness at the shoulder), VACCINATION SITE SWELLING (swollen injection site) and ARTHRALGIA (sore shoulder muscle) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes at the clavicle lateral to the injection site). On an unknown date, the patient experienced ARTHRALGIA (soreness at the shoulder), VACCINATION SITE SWELLING (swollen injection site) and ARTHRALGIA (sore shoulder muscle). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes at the clavicle lateral to the injection site), ARTHRALGIA (soreness at the shoulder), VACCINATION SITE SWELLING (swollen injection site) and ARTHRALGIA (sore shoulder muscle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Malaise, Nausea, Pain in extremity, Vomiting
Clinical narrative: Felt sick; Dizzy; Nauseous; Threw up a little bit; Arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was a little sore), MALAISE (Felt sick), DIZZINESS (Dizzy), NAUSEA (Nauseous) and VOMITING (Threw up a little bit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was a little sore). On 02-Mar-2021, the patient experienced MALAISE (Felt sick), DIZZINESS (Dizzy), NAUSEA (Nauseous) and VOMITING (Threw up a little bit). At the time of the report, PAIN IN EXTREMITY (Arm was a little sore), MALAISE (Felt sick), DIZZINESS (Dizzy), NAUSEA (Nauseous) and VOMITING (Threw up a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Headache; Tired Feeling; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and FATIGUE (Tired Feeling) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache) and FATIGUE (Tired Feeling). At the time of the report, HEADACHE (Headache) and FATIGUE (Tired Feeling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant product was reported.  no treatment product was reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: positive for covid19; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (positive for covid19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (positive for covid19). At the time of the report, COVID-19 (positive for covid19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: postive (Positive) positive test.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Swollen tongue, Tongue erythema
Clinical narrative: Swelling and redness in the tongue; redness in the tongue; eventually became generalized.; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Mar-2021. The most recent information was received on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Swelling and redness in the tongue), TONGUE ERYTHEMA (redness in the tongue) and ERYTHEMA (eventually became generalized.) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWOLLEN TONGUE (Swelling and redness in the tongue), TONGUE ERYTHEMA (redness in the tongue) and ERYTHEMA (eventually became generalized.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Swelling of tongue, Tongue redness and Redness, at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (Swelling and redness in the tongue), TONGUE ERYTHEMA (redness in the tongue) and ERYTHEMA (eventually became generalized.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medicines were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Significant follow up received, added patient demographics, updated event outcome to recovered
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Influenza like illness
Clinical narrative: Since first shot having very mild temperature; flu like symptoms; Since first shot having chills on the evenings; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE INCREASED (Since first shot having very mild temperature), INFLUENZA LIKE ILLNESS (flu like symptoms) and CHILLS (Since first shot having chills on the evenings) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     Concomitant products included VITAMIN D3 for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced BODY TEMPERATURE INCREASED (Since first shot having very mild temperature), INFLUENZA LIKE ILLNESS (flu like symptoms) and CHILLS (Since first shot having chills on the evenings). The patient was treated with IBUPROFEN for Fever and Pain, at an unspecified dose and frequency. At the time of the report, BODY TEMPERATURE INCREASED (Since first shot having very mild temperature), INFLUENZA LIKE ILLNESS (flu like symptoms) and CHILLS (Since first shot having chills on the evenings) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included 5 pills for blood pressure, gaud medication, stomach pills.   This case was linked to US-MODERNATX, INC.-MOD-2021-056373 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056373:Case for second dose
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dysstasia, Fatigue, Vaccination site pain
Clinical narrative: I cant stand up, as my legs are bucking up; fatigue; felt weak; soreness at injection site of left arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (felt weak), DYSSTASIA (I cant stand up, as my legs are bucking up), VACCINATION SITE PAIN (soreness at injection site of left arm) and FATIGUE (fatigue) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Cholesterol, NORTRIPTYLINE for Depression, LISINOPRIL and FUROSEMIDE for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced ASTHENIA (felt weak) and VACCINATION SITE PAIN (soreness at injection site of left arm). On 09-Mar-2021, the patient experienced DYSSTASIA (I cant stand up, as my legs are bucking up) and FATIGUE (fatigue). On 10-Mar-2021, ASTHENIA (felt weak), DYSSTASIA (I cant stand up, as my legs are bucking up) and FATIGUE (fatigue) had resolved. At the time of the report, VACCINATION SITE PAIN (soreness at injection site of left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Blood pressure pills.   This case was linked to US-MODERNATX, INC.-MOD-2021-056729 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056729:cross-linked case
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Pain, Pain in extremity
Clinical narrative: Hurting all over body; Short term memory feels affected; Arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm sore), PAIN (Hurting all over body) and AMNESIA (Short term memory feels affected) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 037A21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE for an unknown indication.   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm sore). On 25-Feb-2021, the patient experienced PAIN (Hurting all over body) and AMNESIA (Short term memory feels affected). At the time of the report, PAIN IN EXTREMITY (Arm sore), PAIN (Hurting all over body) and AMNESIA (Short term memory feels affected) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication were not provided.   This case was linked to INC.-MOD-2021-056418 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow-up information received on 03-Jun-2021, contains Non significant information.; Sender's Comments: INC.-MOD-2021-056418:Second Dose.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose, Vaccination error, Wrong technique in device usage process
Clinical narrative: The same vials were used to give vaccinate; Administration of an invalid dose; Used partially; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Used partially), WRONG TECHNIQUE IN DEVICE USAGE PROCESS (The same vials were used to give vaccinate) and VACCINATION ERROR (Administration of an invalid dose) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Past medical history not provided).    On 22-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 19-Mar-2021, the patient experienced UNDERDOSE (Used partially). On 22-Mar-2021, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (The same vials were used to give vaccinate) and VACCINATION ERROR (Administration of an invalid dose). On 19-Mar-2021, UNDERDOSE (Used partially) had resolved. On 22-Mar-2021, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (The same vials were used to give vaccinate) and VACCINATION ERROR (Administration of an invalid dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications taken by the patient were not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-056335 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: delayed reaction of a rash on arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (delayed reaction of a rash on arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (delayed reaction of a rash on arm). At the time of the report, RASH (delayed reaction of a rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-056129 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-056129:patient 1- first dose
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Chills, Cough, Fatigue
Clinical narrative: cough; joint ache(all); headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), ARTHRALGIA (joint ache(all)), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 respiratory infection in January 2021 and Stress.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough), ARTHRALGIA (joint ache(all)), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, COUGH (cough), ARTHRALGIA (joint ache(all)), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's relevant concomitant medications weren't reported Treatment information was not provided
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: cough; joint ache(all); headache; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), ARTHRALGIA (joint ache(all)), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 respiratory infection in January 2021 and Stress.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough), ARTHRALGIA (joint ache(all)), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills). At the time of the report, COUGH (cough), ARTHRALGIA (joint ache(all)), HEADACHE (headache), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's relevant concomitant medications weren't reported Treatment information was not provided